9 March 2017 In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study
Author Affiliations +
Abstract
Expensive and lengthy clinical trials can delay regulatory evaluation and add significant burden that stifles innovation affecting patient access to novel, high-quality imaging technologies. In silico imaging holds promise for evaluating the safety and effectiveness of imaging technologies with much less burden than clinical trials. We define in silico imaging as a computer simulation of an entire imaging system (including source, object, task, and observer components) used for research, development, optimization, technology assessment, and regulatory evaluation of new technology. In this work we describe VICTRE (our study of virtual imaging clinical trials for regulatory evaluation) and the considerations for building an entire imaging pipeline in silico including device (physics), patient (anatomy, disease), and image interpretation models for regulatory evaluation using open-source tools.
Conference Presentation
© (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Aldo Badano, Andreu Badal, Stephen Glick, Christian G. Graff, Frank Samuelson, Diksha Sharma, Rongping Zeng, "In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study", Proc. SPIE 10132, Medical Imaging 2017: Physics of Medical Imaging, 1013220 (9 March 2017); doi: 10.1117/12.2255746; https://doi.org/10.1117/12.2255746
PROCEEDINGS
6 PAGES + PRESENTATION

SHARE
Back to Top